Loading…
Effect of 5-aminolevulinic acid on the expression of carcinogenesis-related proteins in cultured primary hepatocytes
Acute intermittent porphyria (AIP) is a heme pathway disorder caused by a decrease in the activity and synthesis of porphobilinogen deaminase. Thus, the first heme precursor 5-aminolevulinic acid (ALA) accumulates in the liver. Reactive oxygen species (ROS) resulting from ALA oxidation may be correl...
Saved in:
Published in: | Molecular biology reports 2018-12, Vol.45 (6), p.2801-2809 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c438t-6cf8b15518653a1323cb1f7f14d1959acf977b582a1f7977b2f67ad6b88964943 |
---|---|
cites | cdi_FETCH-LOGICAL-c438t-6cf8b15518653a1323cb1f7f14d1959acf977b582a1f7977b2f67ad6b88964943 |
container_end_page | 2809 |
container_issue | 6 |
container_start_page | 2801 |
container_title | Molecular biology reports |
container_volume | 45 |
creator | Menezes, P. R. González, C. B. DeSouza, A. O. Maria, D. A. Onuki, J. |
description | Acute intermittent porphyria (AIP) is a heme pathway disorder caused by a decrease in the activity and synthesis of porphobilinogen deaminase. Thus, the first heme precursor 5-aminolevulinic acid (ALA) accumulates in the liver. Reactive oxygen species (ROS) resulting from ALA oxidation may be correlated to a higher incidence of hepatocellular carcinoma (HCC) in AIP patients. However, the molecular mechanisms of this relationship have not been thoroughly elucidated to date. In this study, we investigated the effect of increasing levels of ALA on the expression of proteins related to DNA repair, oxidative stress, apoptosis, proliferation and lipid metabolism. Primary rat hepatocytes were isolated by the collagenase perfusion method, lipoperoxidation was evaluated by a TBA fluorimetric assay and Western blotting was used to assess protein abundance. The data showed that ALA treatment promoted a dose-dependent increase of p53 expression, downregulation of Bcl-2, HMG-CoA reductase and OGG1 and an increase in lipoperoxidation. There was no alteration in the expression of the transcription factor NF-κB, catalase and superoxide dismutase. ALA oxidation products induced protein regulation patterns, suggesting the interconnection of cellular processes, such as the intrinsic pathway of apoptosis, redox homeostasis, cell proliferation, lipid metabolism and DNA repair. This study helps to elucidate the molecular mechanisms of hepatotoxicity mediated by ALA pro-oxidant effects and supports the hypothesis that ALA accumulation correlates with a higher incidence of hepatic carcinogenic events. |
doi_str_mv | 10.1007/s11033-018-4367-5 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2103990150</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2103990150</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-6cf8b15518653a1323cb1f7f14d1959acf977b582a1f7977b2f67ad6b88964943</originalsourceid><addsrcrecordid>eNp1kMFO3DAQhq0KxG6BB-gFWeLs1hPHsXNEq6UgIfUCZ8txxmCUTRbbqdi3r7e7lFNPtsff_DP6CPkG_Dtwrn4kAC4E46BZLRrF5BeyBKkEq1ulT8iSCw6s1hIW5GtKr5zzGpQ8IwvBK9BCVkuS196jy3TyVDK7CeM04O95CGNw1LrQ02mk-QUpvm8jphTKs6DORlfQZxwxhcQiDjZjT7dxyhjGRMNI3TzkOf4tho2NO_qCW5snt8uYLsipt0PCy-N5Tp5u14-rO_bw6-f96uaBuVrozBrndQdSgm6ksCAq4TrwykPdQytb63yrVCd1ZUt1f618o2zfdFq3Td3W4pxcH3LLYm8zpmxepzmOZaSpirm25SB5oeBAuTilFNGb48oGuNl7NgfPpng2e89Glp6rY_LcbbD_1_EhtgDVAUjla3zG-Dn6_6l_AApxiVc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2103990150</pqid></control><display><type>article</type><title>Effect of 5-aminolevulinic acid on the expression of carcinogenesis-related proteins in cultured primary hepatocytes</title><source>Springer Nature</source><creator>Menezes, P. R. ; González, C. B. ; DeSouza, A. O. ; Maria, D. A. ; Onuki, J.</creator><creatorcontrib>Menezes, P. R. ; González, C. B. ; DeSouza, A. O. ; Maria, D. A. ; Onuki, J.</creatorcontrib><description>Acute intermittent porphyria (AIP) is a heme pathway disorder caused by a decrease in the activity and synthesis of porphobilinogen deaminase. Thus, the first heme precursor 5-aminolevulinic acid (ALA) accumulates in the liver. Reactive oxygen species (ROS) resulting from ALA oxidation may be correlated to a higher incidence of hepatocellular carcinoma (HCC) in AIP patients. However, the molecular mechanisms of this relationship have not been thoroughly elucidated to date. In this study, we investigated the effect of increasing levels of ALA on the expression of proteins related to DNA repair, oxidative stress, apoptosis, proliferation and lipid metabolism. Primary rat hepatocytes were isolated by the collagenase perfusion method, lipoperoxidation was evaluated by a TBA fluorimetric assay and Western blotting was used to assess protein abundance. The data showed that ALA treatment promoted a dose-dependent increase of p53 expression, downregulation of Bcl-2, HMG-CoA reductase and OGG1 and an increase in lipoperoxidation. There was no alteration in the expression of the transcription factor NF-κB, catalase and superoxide dismutase. ALA oxidation products induced protein regulation patterns, suggesting the interconnection of cellular processes, such as the intrinsic pathway of apoptosis, redox homeostasis, cell proliferation, lipid metabolism and DNA repair. This study helps to elucidate the molecular mechanisms of hepatotoxicity mediated by ALA pro-oxidant effects and supports the hypothesis that ALA accumulation correlates with a higher incidence of hepatic carcinogenic events.</description><identifier>ISSN: 0301-4851</identifier><identifier>EISSN: 1573-4978</identifier><identifier>DOI: 10.1007/s11033-018-4367-5</identifier><identifier>PMID: 30218352</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Aminolevulinic acid ; Aminolevulinic Acid - pharmacology ; Animal Anatomy ; Animal Biochemistry ; Animals ; Apoptosis ; Apoptosis - drug effects ; Bcl-2 protein ; Biomedical and Life Sciences ; Carcinogenesis ; Carcinogenesis - drug effects ; Carcinoma, Hepatocellular - metabolism ; Catalase ; Cell proliferation ; Cell Proliferation - drug effects ; Collagen ; Collagenase ; DNA repair ; DNA Repair - drug effects ; Gene Expression Regulation - drug effects ; Heme ; Hepatocellular carcinoma ; Hepatocytes ; Hepatocytes - drug effects ; Hepatotoxicity ; Histology ; Homeostasis ; Hydroxymethylbilane synthase ; Hydroxymethylglutaryl-CoA reductase ; Life Sciences ; Lipid metabolism ; Lipid Metabolism - drug effects ; Liver - drug effects ; Liver cancer ; Liver Neoplasms - metabolism ; Male ; Metabolism ; Molecular modelling ; Morphology ; NF-κB protein ; OGG1 protein ; Oxidation ; Oxidative stress ; Oxidative Stress - drug effects ; Porphyria ; Primary Cell Culture ; Rats ; Rats, Wistar ; Reactive Oxygen Species ; Short Communication ; Superoxide Dismutase ; Western blotting</subject><ispartof>Molecular biology reports, 2018-12, Vol.45 (6), p.2801-2809</ispartof><rights>Springer Nature B.V. 2018</rights><rights>Molecular Biology Reports is a copyright of Springer, (2018). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-6cf8b15518653a1323cb1f7f14d1959acf977b582a1f7977b2f67ad6b88964943</citedby><cites>FETCH-LOGICAL-c438t-6cf8b15518653a1323cb1f7f14d1959acf977b582a1f7977b2f67ad6b88964943</cites><orcidid>0000-0001-5343-8848 ; 0000-0002-0527-5877 ; 0000-0001-7676-9551 ; 0000-0002-5629-1594 ; 0000-0001-6025-7500</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30218352$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Menezes, P. R.</creatorcontrib><creatorcontrib>González, C. B.</creatorcontrib><creatorcontrib>DeSouza, A. O.</creatorcontrib><creatorcontrib>Maria, D. A.</creatorcontrib><creatorcontrib>Onuki, J.</creatorcontrib><title>Effect of 5-aminolevulinic acid on the expression of carcinogenesis-related proteins in cultured primary hepatocytes</title><title>Molecular biology reports</title><addtitle>Mol Biol Rep</addtitle><addtitle>Mol Biol Rep</addtitle><description>Acute intermittent porphyria (AIP) is a heme pathway disorder caused by a decrease in the activity and synthesis of porphobilinogen deaminase. Thus, the first heme precursor 5-aminolevulinic acid (ALA) accumulates in the liver. Reactive oxygen species (ROS) resulting from ALA oxidation may be correlated to a higher incidence of hepatocellular carcinoma (HCC) in AIP patients. However, the molecular mechanisms of this relationship have not been thoroughly elucidated to date. In this study, we investigated the effect of increasing levels of ALA on the expression of proteins related to DNA repair, oxidative stress, apoptosis, proliferation and lipid metabolism. Primary rat hepatocytes were isolated by the collagenase perfusion method, lipoperoxidation was evaluated by a TBA fluorimetric assay and Western blotting was used to assess protein abundance. The data showed that ALA treatment promoted a dose-dependent increase of p53 expression, downregulation of Bcl-2, HMG-CoA reductase and OGG1 and an increase in lipoperoxidation. There was no alteration in the expression of the transcription factor NF-κB, catalase and superoxide dismutase. ALA oxidation products induced protein regulation patterns, suggesting the interconnection of cellular processes, such as the intrinsic pathway of apoptosis, redox homeostasis, cell proliferation, lipid metabolism and DNA repair. This study helps to elucidate the molecular mechanisms of hepatotoxicity mediated by ALA pro-oxidant effects and supports the hypothesis that ALA accumulation correlates with a higher incidence of hepatic carcinogenic events.</description><subject>Aminolevulinic acid</subject><subject>Aminolevulinic Acid - pharmacology</subject><subject>Animal Anatomy</subject><subject>Animal Biochemistry</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Bcl-2 protein</subject><subject>Biomedical and Life Sciences</subject><subject>Carcinogenesis</subject><subject>Carcinogenesis - drug effects</subject><subject>Carcinoma, Hepatocellular - metabolism</subject><subject>Catalase</subject><subject>Cell proliferation</subject><subject>Cell Proliferation - drug effects</subject><subject>Collagen</subject><subject>Collagenase</subject><subject>DNA repair</subject><subject>DNA Repair - drug effects</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Heme</subject><subject>Hepatocellular carcinoma</subject><subject>Hepatocytes</subject><subject>Hepatocytes - drug effects</subject><subject>Hepatotoxicity</subject><subject>Histology</subject><subject>Homeostasis</subject><subject>Hydroxymethylbilane synthase</subject><subject>Hydroxymethylglutaryl-CoA reductase</subject><subject>Life Sciences</subject><subject>Lipid metabolism</subject><subject>Lipid Metabolism - drug effects</subject><subject>Liver - drug effects</subject><subject>Liver cancer</subject><subject>Liver Neoplasms - metabolism</subject><subject>Male</subject><subject>Metabolism</subject><subject>Molecular modelling</subject><subject>Morphology</subject><subject>NF-κB protein</subject><subject>OGG1 protein</subject><subject>Oxidation</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>Porphyria</subject><subject>Primary Cell Culture</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Reactive Oxygen Species</subject><subject>Short Communication</subject><subject>Superoxide Dismutase</subject><subject>Western blotting</subject><issn>0301-4851</issn><issn>1573-4978</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kMFO3DAQhq0KxG6BB-gFWeLs1hPHsXNEq6UgIfUCZ8txxmCUTRbbqdi3r7e7lFNPtsff_DP6CPkG_Dtwrn4kAC4E46BZLRrF5BeyBKkEq1ulT8iSCw6s1hIW5GtKr5zzGpQ8IwvBK9BCVkuS196jy3TyVDK7CeM04O95CGNw1LrQ02mk-QUpvm8jphTKs6DORlfQZxwxhcQiDjZjT7dxyhjGRMNI3TzkOf4tho2NO_qCW5snt8uYLsipt0PCy-N5Tp5u14-rO_bw6-f96uaBuVrozBrndQdSgm6ksCAq4TrwykPdQytb63yrVCd1ZUt1f618o2zfdFq3Td3W4pxcH3LLYm8zpmxepzmOZaSpirm25SB5oeBAuTilFNGb48oGuNl7NgfPpng2e89Glp6rY_LcbbD_1_EhtgDVAUjla3zG-Dn6_6l_AApxiVc</recordid><startdate>20181201</startdate><enddate>20181201</enddate><creator>Menezes, P. R.</creator><creator>González, C. B.</creator><creator>DeSouza, A. O.</creator><creator>Maria, D. A.</creator><creator>Onuki, J.</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><orcidid>https://orcid.org/0000-0001-5343-8848</orcidid><orcidid>https://orcid.org/0000-0002-0527-5877</orcidid><orcidid>https://orcid.org/0000-0001-7676-9551</orcidid><orcidid>https://orcid.org/0000-0002-5629-1594</orcidid><orcidid>https://orcid.org/0000-0001-6025-7500</orcidid></search><sort><creationdate>20181201</creationdate><title>Effect of 5-aminolevulinic acid on the expression of carcinogenesis-related proteins in cultured primary hepatocytes</title><author>Menezes, P. R. ; González, C. B. ; DeSouza, A. O. ; Maria, D. A. ; Onuki, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-6cf8b15518653a1323cb1f7f14d1959acf977b582a1f7977b2f67ad6b88964943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aminolevulinic acid</topic><topic>Aminolevulinic Acid - pharmacology</topic><topic>Animal Anatomy</topic><topic>Animal Biochemistry</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Bcl-2 protein</topic><topic>Biomedical and Life Sciences</topic><topic>Carcinogenesis</topic><topic>Carcinogenesis - drug effects</topic><topic>Carcinoma, Hepatocellular - metabolism</topic><topic>Catalase</topic><topic>Cell proliferation</topic><topic>Cell Proliferation - drug effects</topic><topic>Collagen</topic><topic>Collagenase</topic><topic>DNA repair</topic><topic>DNA Repair - drug effects</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Heme</topic><topic>Hepatocellular carcinoma</topic><topic>Hepatocytes</topic><topic>Hepatocytes - drug effects</topic><topic>Hepatotoxicity</topic><topic>Histology</topic><topic>Homeostasis</topic><topic>Hydroxymethylbilane synthase</topic><topic>Hydroxymethylglutaryl-CoA reductase</topic><topic>Life Sciences</topic><topic>Lipid metabolism</topic><topic>Lipid Metabolism - drug effects</topic><topic>Liver - drug effects</topic><topic>Liver cancer</topic><topic>Liver Neoplasms - metabolism</topic><topic>Male</topic><topic>Metabolism</topic><topic>Molecular modelling</topic><topic>Morphology</topic><topic>NF-κB protein</topic><topic>OGG1 protein</topic><topic>Oxidation</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>Porphyria</topic><topic>Primary Cell Culture</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Reactive Oxygen Species</topic><topic>Short Communication</topic><topic>Superoxide Dismutase</topic><topic>Western blotting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Menezes, P. R.</creatorcontrib><creatorcontrib>González, C. B.</creatorcontrib><creatorcontrib>DeSouza, A. O.</creatorcontrib><creatorcontrib>Maria, D. A.</creatorcontrib><creatorcontrib>Onuki, J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Health & Medicine (ProQuest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><jtitle>Molecular biology reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Menezes, P. R.</au><au>González, C. B.</au><au>DeSouza, A. O.</au><au>Maria, D. A.</au><au>Onuki, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of 5-aminolevulinic acid on the expression of carcinogenesis-related proteins in cultured primary hepatocytes</atitle><jtitle>Molecular biology reports</jtitle><stitle>Mol Biol Rep</stitle><addtitle>Mol Biol Rep</addtitle><date>2018-12-01</date><risdate>2018</risdate><volume>45</volume><issue>6</issue><spage>2801</spage><epage>2809</epage><pages>2801-2809</pages><issn>0301-4851</issn><eissn>1573-4978</eissn><abstract>Acute intermittent porphyria (AIP) is a heme pathway disorder caused by a decrease in the activity and synthesis of porphobilinogen deaminase. Thus, the first heme precursor 5-aminolevulinic acid (ALA) accumulates in the liver. Reactive oxygen species (ROS) resulting from ALA oxidation may be correlated to a higher incidence of hepatocellular carcinoma (HCC) in AIP patients. However, the molecular mechanisms of this relationship have not been thoroughly elucidated to date. In this study, we investigated the effect of increasing levels of ALA on the expression of proteins related to DNA repair, oxidative stress, apoptosis, proliferation and lipid metabolism. Primary rat hepatocytes were isolated by the collagenase perfusion method, lipoperoxidation was evaluated by a TBA fluorimetric assay and Western blotting was used to assess protein abundance. The data showed that ALA treatment promoted a dose-dependent increase of p53 expression, downregulation of Bcl-2, HMG-CoA reductase and OGG1 and an increase in lipoperoxidation. There was no alteration in the expression of the transcription factor NF-κB, catalase and superoxide dismutase. ALA oxidation products induced protein regulation patterns, suggesting the interconnection of cellular processes, such as the intrinsic pathway of apoptosis, redox homeostasis, cell proliferation, lipid metabolism and DNA repair. This study helps to elucidate the molecular mechanisms of hepatotoxicity mediated by ALA pro-oxidant effects and supports the hypothesis that ALA accumulation correlates with a higher incidence of hepatic carcinogenic events.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>30218352</pmid><doi>10.1007/s11033-018-4367-5</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-5343-8848</orcidid><orcidid>https://orcid.org/0000-0002-0527-5877</orcidid><orcidid>https://orcid.org/0000-0001-7676-9551</orcidid><orcidid>https://orcid.org/0000-0002-5629-1594</orcidid><orcidid>https://orcid.org/0000-0001-6025-7500</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0301-4851 |
ispartof | Molecular biology reports, 2018-12, Vol.45 (6), p.2801-2809 |
issn | 0301-4851 1573-4978 |
language | eng |
recordid | cdi_proquest_journals_2103990150 |
source | Springer Nature |
subjects | Aminolevulinic acid Aminolevulinic Acid - pharmacology Animal Anatomy Animal Biochemistry Animals Apoptosis Apoptosis - drug effects Bcl-2 protein Biomedical and Life Sciences Carcinogenesis Carcinogenesis - drug effects Carcinoma, Hepatocellular - metabolism Catalase Cell proliferation Cell Proliferation - drug effects Collagen Collagenase DNA repair DNA Repair - drug effects Gene Expression Regulation - drug effects Heme Hepatocellular carcinoma Hepatocytes Hepatocytes - drug effects Hepatotoxicity Histology Homeostasis Hydroxymethylbilane synthase Hydroxymethylglutaryl-CoA reductase Life Sciences Lipid metabolism Lipid Metabolism - drug effects Liver - drug effects Liver cancer Liver Neoplasms - metabolism Male Metabolism Molecular modelling Morphology NF-κB protein OGG1 protein Oxidation Oxidative stress Oxidative Stress - drug effects Porphyria Primary Cell Culture Rats Rats, Wistar Reactive Oxygen Species Short Communication Superoxide Dismutase Western blotting |
title | Effect of 5-aminolevulinic acid on the expression of carcinogenesis-related proteins in cultured primary hepatocytes |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T10%3A57%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%205-aminolevulinic%20acid%20on%20the%20expression%20of%20carcinogenesis-related%20proteins%20in%20cultured%20primary%20hepatocytes&rft.jtitle=Molecular%20biology%20reports&rft.au=Menezes,%20P.%20R.&rft.date=2018-12-01&rft.volume=45&rft.issue=6&rft.spage=2801&rft.epage=2809&rft.pages=2801-2809&rft.issn=0301-4851&rft.eissn=1573-4978&rft_id=info:doi/10.1007/s11033-018-4367-5&rft_dat=%3Cproquest_cross%3E2103990150%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c438t-6cf8b15518653a1323cb1f7f14d1959acf977b582a1f7977b2f67ad6b88964943%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2103990150&rft_id=info:pmid/30218352&rfr_iscdi=true |